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Adhesion of calcium oxalate (CaOx) crystals to kidney cells
may be a key event in the pathogenesis of kidney stones
associated with marked hyperoxaluria. Previously, we found
that 1,2,3,4,6-penta-O-galloyl-b-D-glucose (PGG), isolated
from a traditional medicinal herb, reduced CaOx crystal
adhesion to renal epithelial cells by acting on the cells as well
as on the crystal surface. Here we used the ethylene glycol
(EG)-mediated hyperoxaluric rat model and found evidence
of oxidant stress as indicated by decreases in the activities of
the renal antioxidant enzymes, superoxide dismutase,
catalase, and glutathione peroxidase, with increased kidney
cell apoptosis and serum malondialdehyde levels, all evident
by 21 days of EG treatment. These effects of hyperoxaluria
were reversed by concurrent PGG treatment along with
decreased urinary oxalate levels and CaOx supersaturation.
Renal epithelial cell expression of the crystal binding
molecule hyaluronan increased diffusely within 7 days of EG
initiation, suggesting it is not a result of but precedes crystal
deposition. Renal cell osteopontin (OPN) was also
upregulated in EG-treated animals, and PGG significantly
attenuated overexpression of both OPN and hyaluronan.
Thus, our findings demonstrate that PGG reduces renal
crystallization and oxidative renal cell injury, and may be a
candidate chemopreventive agent for nephrolithiasis.
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The majority (B70%) of human kidney stones contain
calcium oxalate (CaOx). However, the mechanisms of renal
stone formation are poorly understood. Although urinary
supersaturation with calcium and oxalate is a known
important factor, the treatment strategies aimed to reduce
urinary supersaturation are only partially effective and stone
recurrence is still common. Furthermore, the pathways from
urinary supersaturation to kidney stone are poorly defined.
In states of marked hyperoxaluria, such as primary and
enteric hyperoxaluria, oxalate-induced oxidative stress and/or
adhesion of CaOx crystals to renal cells may be important
events. In all types of stone disease additional therapeutics are
required.1
Several recent studies have highlighted the potential
efficacy of several Oriental medicinal herbs or natural
compounds for the treatment of nephrolithiasis. For
example, Al-Ghamdi et al.2 demonstrated that Cymbopogon
schoenanthus extract inhibited CaOx deposition in ethylene
glycol (EG)-treated male Wistar albino rats. Similarly,
Yuliana et al.3 suggested that methoxy flavonoids from
Orthosiphon stamineus Benth, an Indonesian medicinal
herb, can prevent crystallization in a rat kidney stone model.
Green tea and its major component, epigallocatechin-3-
gallate, were also reported to inhibit kidney stone formation
in vitro and in vivo.4,5 Recently, our group reported that
1,2,3,4,6-penta-O-galloyl-b-D-glucose (PGG), a water soluble
gallotannin just like epigallocatechin-3-gallate, attenuated
CaOx crystal adhesion to renal epithelial cells, perhaps via
effects on hyaluronan expression.6
Therefore, this study was conducted to evaluate the in vivo
efficacy of PGG for the prevention of crystallization, renal
injury, and oxidative stress in a hyperoxaluric rat model
induced by 0.8% EG and 1% ammonium chloride.
RESULTS
PGG reduces crystalluria and urinary oxalate excretion in
EG-treated rats
Rats were studied 7, 14, and 21 days after initiation of EG
treatment. PGG significantly reduced CaOx crystalluria
(Figure 1a), intrarenal CaOx crystal deposition (Figure 1b),
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and urinary oxalate excretion (Table 1) compared with
animals treated with EG alone. Renal function was preserved
in all animals for this 3-week study (Table 2). Urinary oxalate
excretion and CaOx supersaturation, assessed using the AP
Tiselius index,7 were both decreased by PGG at the higher
20mg/kg dose (Table 1).
Oxalate increases ROS production and induces oxidative
renal cell injury in human renal cells
Previous studies have suggested that oxalate can injure renal
cells, in part, through oxidative stress pathways,8 and this
injury may promote renal crystal deposition.9 To assess the
effect of PGG on oxalate-induced oxidative stress, human
renal cells (HRCs) were exposed to 1mM oxalate in vitro.
PGG at 25 or 50 mM markedly reduced reactive oxygen species
(ROS) production of the cells from 33 to 8.3% and 5%,
respectively (Figure 2a). Serum malondialdehyde (MDA) levels
were also increased by day 21 in EG-treated animals, and this
increase was blunted by concurrent administration of PGG
(Figure 2b).
PGG enhances antioxidant enzyme activities in hyperoxaluric
rat kidneys
To further define the effects of PGG on oxalate-induced
oxidative stress, intrarenal expression of antioxidant enzymes
was analyzed. EG treatment reduced renal superoxide
dismutase (SOD) expression at 7 and 14 days, and even
more dramatically by day 21 (Figure 3a). Concurrent
administration of PGG, however, increased renal SOD by
immunohistochemistry (Figure 3a) or western blot (Figure 3b).
Similarly, PGG significantly enhanced renal expression of the
antioxidant enzymes catalase and glutathione peroxidase in
EG-treated rats (Figure 3c).
PGG significantly reduces renal osteopontin expression and
apoptosis induced by hyperoxaluria
Previous studies have suggested that renal expression of OPN
is upregulated in response to renal injury,10–12 including that
induced by EG.13 Immunohistochemistry and western
blotting confirmed that renal expression of OPN was
enhanced 21 days after initiation of EG treatment (Figure 4
and Supplementary Figure S1 online). PGG significantly
blunted this increase in OPN expression in a dose-dependent
manner (Figure 4). To further evaluate a potential protective
effect of PGG, renal cell apoptosis was assessed by terminal
deoxytransferase uridine triphosphate nick end labeling
(TUNEL) assay. The number of TUNEL-positive cells was
dramatically increased by EG treatment to 24%, but this
increase was dramatically blunted by concurrent PGG
treatment (9 and 7% at 4 and 20mg/kg, respectively,
Figure 5). These results suggest that PGG can prevent
oxalate-induced renal cell injury induced by EG.
PGG attenuates renal hyaluronan expression in EG-treated
rat kidneys
Hyaluronan (hyaluronic acid) is secreted and expressed by
proliferating renal tubular cells as a crystal-binding mole-
cule.14–17 In our previous study, PGG decreased hyaluronan
expression in scrape-wounded MDCK I cell monolayers.6 In
the current in vivo study, PGG also significantly reduced renal
tubular cell hyaluronan expression on days 7 and 14 after
initiation of injury by hyperoxaluria (Figure 6). Furthermore,
the increase in hyaluronan expression was diffuse and did not
colocalize with crystal deposits (Figure 6a).
DISCUSSION
Nephrolithiasis is a common, painful, and costly condition.
CaOx stones are by far the most common, accounting for up
to 70% of cases.18 Among those with extreme hyperoxaluria,
such as seen in patients with primary or enteric hyperox-
aluria, oxalate-induced cell damage and crystal adhesion to
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Figure 1 | Effect of 1,2,3,4,6-penta-O-galloyl-b-D-glucose (PGG)
on calcium oxalate (CaOx) crystal deposition in ethylene
glycol (EG)-treated rat urine and kidneys. (a) Twenty-four hour
rat urine samples on days 7, 14, and 21 were collected on ice in a
metabolic cage and CaOx crystals with tetragonal bipyramidal
habit were counted in a hemocytometer at  400 magnification.
Graph represents the average number of urinary CaOx crystals
in the rat urine per high power field. (b) Histological specimens
of rat kidney tissues (n¼ 6/group) obtained on days 7, 14, and
21 following EG treatment were stained with hematoxylin and
eosin (H&E), and the number of crystal depositions was counted.
Graph represents the average number of crystal deposits in
the kidney per high power field. Data represent means±s.d.
*Po0.05, **Po0.01, and ***Po0.001 versus untreated control;
###Po0.001 versus EG; and !!!Po0.001 versus EGþ P4 two-way
analysis of variance followed by a post hoc analysis. C, untreated
control (distilled water); EG, EG-treated group (0.8% EG/1%
ammonium chloride (AC) (NH4Cl) in drinking water); and EGþ P4
and EGþ P20, two EG- and PGG-treated groups (0.8% EG/1%
ACþ 4 or 20mg/kg of PGG in 2% methylcellulose).
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cells have been implicated. Hyperoxaluric rat models are
often used to model these events, either induced by EG
alone19,20 or in combination with ammonium chloride.18,21
Therefore, in this study, the mechanism(s) whereby PGG
isolated from a gallnut of Rhus chinensis MILL or Paeonia
lactiflora alters CaOx crystal adhesion to cells and oxalate-
induced renal cell injury was examined in rats treated with
0.8% EG and 1% ammonium chloride for 1, 2, and 3 weeks
to confirm our previous in vitro data that PGG inhibits
kidney stone formation.6
Kidney stone formation involves a cascade of events
including one or more of the following: urinary super-
saturation, crystal nucleation, growth, and aggregation;
retention of crystals in the renal tubules or interstitium;
and growth of a calculus upon a tubular plug or interstitial
deposit (so-called Randall’s Plaque).22 In this study, PGG
significantly decreased renal CaOx crystal deposition com-
pared with animals treated with EG alone. Our results suggest
that multiple factors may contribute to the protective effect
of PGG, including decreased urinary oxalate excretion and
supersaturation, decreased renal oxidative injury, and
decreased expression of the renal cell crystal binding
molecule hyaluronan. Our previous in vitro study also
suggested that PGG can exert effects on the surface of CaOx
crystals and renal cells that decrease their propensity to
adhere.6
Evidence implicates free radical production, lipid peroxi-
dation, and renal tubular epithelial cell injury during kidney
stone formation.9,23,24 Therefore, antioxidant agents such as
epigallocatechin-3-gallate, vitamin E, DL a´-lipoic acid, and
green tea were considered potential therapeutics for kidney
stone formation.5,22,25,26 Atorvastatin, a cholesterol-lowering
drug with antioxidant activity, was also reported to inhibit
renal crystal retention in a rat stone-forming model.27
Nonetheless, the relationship between CaOx crystal deposi-
tion and oxidative stress remains unclear. Thamilselvan
et al.29 suggested that oxalate-associated free radical injury
can promote stone formation,28 in part, due to hyperoxalur-
ia-induced peroxidative injury and enhanced CaOx crystal
attachment to renal tubules. Similarly, Schepers et al.30
demonstrated that CaOx crystals generate ROS and cause
acute inflammation-mediated necrotic cell death of renal
proximal tubular cells. Not all studies support this proposed
pathway, as Green et al.31 did not find evidence of lipid
peroxidation in their hyperoxaluric rat model.
Previous in vitro studies suggested that renal cells exposed
to oxalate and/or CaOx crystals generate ROS, thereby
inducing injury and inflammation.32,33 Our in vitro studies
confirmed that 1mM oxalate increased ROS generation
in cultured HRCs, and that this effect was blunted by
PGG. PGG also prevented an increase in serum MDA levels
among EG-treated animals, increased renal levels of anti-
oxidants, and reduced the number of TUNEL-positive cells.
Although the specificity of the TUNEL assay for apoptosis
versus necrosis has been questioned,34 these results all suggest
that PGG can protect against the ROS-induced renal
Table 1 | Urine chemistry
Group
Days after
EG treatment Volume (ml) pH Calcium (mg/day) Oxalate (mg/day) AP (CaOx) index
Untreated control 7 (n=6) 12.66±2.510 7.33±0.577 5.33±1.250 7.21±1.003 2.265±0.136
14 (n=6) 14.30±1.154 8.00±0.001 5.25±0.350 6.93±1.000 2.179±0.033
21 (n=6) 25.00±5.000 7.33±0.577 3.53±0.250 6.82±1.007 2.144±0.029
EG-treated control 7 (n=6) 14.33±5.130 6.33±0.577 2.96±1.360 11.97±1.000 3.761±0.282*
14 (n=4) 18.33±2.880 6.75±0.957 6.50±2.680 12.30±1.026 3.876±1.036*
21 (n=6) 18.80±4.810 6.00±0.001* 4.86±1.270 12.50±1.018* 3.933±1.506**
EG+PGG (4mg/kg) 7 (n=6) 18.60±4.040 6.33±0.577 3.90±1.120 10.56±1.010 3.319±0.496
14 (n=5) 17.50±5.060 6.00±0.001 3.50±1.760## 9.56±1.030* 2.787±0.712
21 (n=6) 30.00±7.900 6.60±1.341 1.70±0.200## 9.86±1.000# 3.098±0.354
EG+PGG (20mg/kg) 7 (n=6) 15.33±4.610 7.16±0.288 2.80±1.550 8.13±1.006 2.552±0.261##
14 (n=6) 17.60±7.820 6.20±0.447 3.10±1.650## 8.87±1.017 2.564±0.099#
21 (n=5) 31.50±12.700 6.00±0.001 1.73±0.005## 9.49±1.0130## 2.928±0.547
Abbreviations: CaOx, calcium oxalate; EG, ethylene glycol; PGG, 1,2,3,4,6-penta-O-galloyl-b-D-glucose.
Urinary oxalate excretion was measured by an enzymatic method using oxalate oxidase. Urinary calcium excretion was measured using Hitachi 747 automatic analyzer by ion
selective electrode method. AP index was calculated with the urinary values of oxalate, calcium, magnesium, citrate, and volume, according to AP index formula:
[(4067Ca0.93Ox0.96) (Mg0.55 (Cit+0.015)0.60 V0.99)]. Data represent means±s.d. *Po0.05 and **Po0.01 versus untreated control; #Po0.05 and ##Po0.01 versus
EG, two-way analysis of variance followed by post hoc analysis.
Table 2 | Blood chemistry
Group
Days after EG
treatment
Albumin
(g/dl)
Creatinine
(mg/dl)
BUN
(mg/dl)
Untreated control 7 4.2±0.305 0.6±0.577 18.3±2.870
14 4.5±0.556 0.8±0.115 20.6±2.084
21 4.6±0.519 0.7±0.100 18.1±0.500
EG-treated control 7 3.8±0.070 0.6±0.070 16.9±3.110
14 3.5±0.173** 0.6±0.141 24.6±15.90
21 3.8±0.273* 0.6±0.044 14.5±1.134
EG+PGG (4mg/kg) 7 3.9±0.305 0.5±0.057 17.6±4.650
14 3.8±0.298 0.6±0.050 19.2±4.860
21 4.1±0.597 0.6±0.173 19.2±7.947
EG+PGG (20mg/kg) 7 4.0±0.353 0.6±0.141 19.5±2.330
14 3.7±0.125* 0.6±0.057 15.2±2.610
21 4.2±0.714 0.7±0.057 14.0±1.997
Abbreviations: BUN, blood urea nitrogen; EG, ethylene glycol; PGG, 1,2,3,4,6-penta-
O-galloyl-b-D-glucose.
Mean±s.d. *Po0.05 and **Po0.01 versus untreated control, two-way analysis of
variance followed by post hoc analysis.
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cell injury death that is associated with EG-induced
hyperoxaluria.
Interestingly, however, PGG also reduced urinary oxalate
excretion and urinary CaOx supersaturation in the EG-
treated animals. The mechanism(s) of this effect is currently
unknown. However, we cannot rule out the possibility that
the reduction in urinary oxalate levels, in part, mediated the
positive effect of PGG in this model. It is important to point
out, however, that renal antioxidant levels were increased
(rather than unchanged) in EG animals given PGG (Figure 3),
and that PGG prevented ROS generation by oxalate-treated
HRCs in vitro (Figure 2). Furthermore, renal hyaluronan
expression was increased within 7 days exposure to EG, and
hyaluronan overexpression was blunted by concurrent PGG
administration. Interestingly, the hyaluronan staining was
diffuse and not restricted to areas of crystal deposition,
suggesting that hyaluronan may be overexpressed by multi-
factors including renal cell injury or crystallization. Our
previous in vitro studies using cultured cells also suggested
that PGG reduced hyaluronan expression on the surface of
proliferating cells.6 Furthermore, PGG decreased OPN over-
expression associated with renal injury induced by EG,
suggesting potential anti-inflammatory effects. Therefore,
our evidence suggests that PGG reduces urinary retention of
CaOx crystals in hyperoxaluric rats, perhaps due to decreased
renal injury and resulting expression of crystal binding
molecules.
In summary, PGG significantly reduced urinary oxalate
excretion, CaOx supersaturation, and renal CaOx crystal
deposition in rats rendered hyperoxaluric with EG. Further-
more, when given together with EG, PGG reduced a serum
marker of oxidative stress (MDA), enhanced the renal
activities of antioxidant enzymes (SOD, catalase, and
glutathione peroxidase), downregulated renal expression of
crystal binding molecules (hyaluronan and OPN), and
reduced renal signs of injury (number of TUNEL-positive
cells). PGG also reduced oxalate-induced ROS generation by
cultured HRCs in vitro. Taken together, our findings
demonstrate that PGG reduces renal crystallization and
oxidative renal cell injury by its antioxidant and anti-CaOx
crystal binding activities, and is a candidate chemopreventive
agent for nephrolithiasis.
MATERIALS AND METHODS
Isolation and identification of PGG
Gallnut of R. chinensis MILL was obtained from the Oriental Medical
Hospital of Kyung Hee University in Seoul and kindly authenticated
by professor Namin Baek in the Department of Oriental Herbal
Materials, Kyung Hee University. The methanol extract (252 g) was
dissolved in distilled water (800ml) and successively fractionated
with equal volumes of n-hexane, ethyl acetate, and butanol with
water; the resulting butanol fraction (35 g) was subjected to silica gel
column chromatography and eluted by chloroform, methanol and
H2O (65:35:10) and ethyl acetate, methanol and H2O (100:15.6:13.5),
followed by purification using high-performance liquid chromato-
graphy (J’sphere ODS-HP80, Kyoto, Japan, 250 20mm ID, S-4mm,
80A, ethyl acetate/methanol/H2O¼ 6:3:1). The active compound was
identified as PGG (molecular weight¼ 940) by nuclear magnetic
resonance and fast atom bombardment mass spectrometry analysis
with a purity of 498% (ref. 35).
Animals
Sprague–Dawley rats weighing 200–220 g (male; n¼ 24) were
purchased from Nara Biotech (Seoul, Republic of Korea) and given
food and water ad libitum. Rats were housed in a room maintained
at 25±1 1C with 55% relative humidity.
Kidney stone model and PGG administration
The rats were divided into four groups (six rats/group): Control
group, EG-treated group, EGþPGG 4mg/kg group, and EGþ PGG
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Figure 2 | Effect of 1,2,3,4,6-penta-O-galloyl-b-D-glucose (PGG)
on ROS production in human renal cells (HRCs) exposed to
calcium oxalate (1mM) and on the serum malondialdehyde
(MDA) level in ethylene glycol (EG)-treated rats. (a) The levels
of ROS in HRCs were measured using ROS-sensitive fluorometric
probe, 2,7-dichlorofluorescein by flow cytometric analysis. Data
are expressed as % cells positive. Data represent means±s.d.
#Po0.05 versus untreated control and **Po0.01 versus oxalate.
(b) The level of serum MDA was determined on days 7, 14,
and 21 following EG treatment (n¼ 6/group) by enzyme-linked
immunosorbent assay colorimetric method. Data represent
means±s.d. ***Po0.001 versus untreated control and
###Po0.001 versus EG, two-way analysis of variance followed by a
post hoc analysis. C, untreated control (distilled water); EG,
EG-treated group (0.8% EG/1% ammonium chloride (AC; NH4Cl) in
drinking water); and EGþ P4 and EGþ P20, two PGG-treated
groups (0.8% EG/1% ACþ 4 or 20mg/kg of PGG in 2%
methylcellulose).
Kidney International (2011) 79, 538–545 541
H-J Lee et al.: PGG reduces renal crystallization and oxidative stress in rat o r ig ina l a r t i c l e
20mg/kg group. Control group rats were given distilled water,
whereas EG-treated animals had 0.8% EG/1% ammonium chloride
(NH4Cl) added to their drinking water to induce hyperoxaluria.
EGþPGG animals were given 0.8% EG/1% ammonium chloride
(NH4Cl) dissolved in their drinking water plus 4 or 20mg/kg PGG
dissolved in 2% methylcellulose by gastric lavage daily for 21 days.
On days 7, 14, and 21 from the beginning of EG treatment, 24-h
urine samples were collected on ice in metabolic cages to measure
the excretion of oxalate and calcium, and blood samples were
collected from the inferior vena cava of rats under ether anesthesia
and immediately frozen at 80 1C before using. The right kidneys
were stored at 70 1C after quick freezing under liquid nitrogen,
and the left kidney was fixed in 4% paraformaldehyde for
physiological examination.
Renal histology
Paraffin-embedded sections (4mm) of rat kidneys were stained with
hematoxylin and eosin (H&E) to quantify crystallization. The
number of crystal deposits in kidney tissue was counted in 10
randomly selected fields and photographed under an Axiovert S 100
light microscope (Carl Zeiss, Weimar, Germany) at  400 magni-
fication.
Urinalysis
Twenty-four hour rat urine samples on days 7, 14, and 21 were
collected on ice in a metabolic cage, and sodium azide was used as a
preservative in the sample collecting tubes containing 6N HCl to
prevent the non-enzymatic conversion of ascorbate to oxalate
during urine collection. The urine was centrifuged at 1300 g for
15min, the pellets were resuspended in 50 ml of water, and crystal
size and quantity were observed in a hemocytometer at  400 magni-
fication under an Axiovert S 100 light microscope (Carl Zeiss).
To measure oxalate concentration in rat urine, reaction reagents
were prepared as follows: reagent A (50mM succinate buffer
containing 0.79mM dimethylaniline and 0.11mM 3-methyl-2-
benzothiazolinone hydrazone, reagent B (100mM EDTA), reagent
C (200mM oxalic acid solution, pH 3.8, 37 1C), and reagent D
(peroxidase enzyme solution). All reagents were equilibrated to
37 1C before using and mixed with rat urine or standards (oxalic
acid) by inversion. Then, reagent E (oxalate oxidase, 0.5U/ml) was
immediately added to the mixture and incubated for 2 h at room
temperature in dark. Optical density was measured using microplate
reader (Molecular Devices, Sunnyvale, CA) at 600 nm.
Concentrations of urine calcium, magnesium, and citrate were
measured by the Green Cross Reference Laboratory (Yongin,
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Figure 3 | Effect of 1,2,3,4,6-penta-O-galloyl-b-D-glucose (PGG) on antioxidant enzyme activity in ethylene glycol (EG)-treated rat
kidneys. (a) Immunohistochemical staining for superoxide dismutase (SOD) expression in rat kidney tissues (n¼ 6/group) obtained on days
7, 14, and 21 following EG treatment was performed and the average number of positive stained cells per high power field was counted
from three independent experiments. Data represent means±s.d. ***Po0.001 versus untreated control; #Po0.05 and ###Po0.001 versus EG;
and !!!Po0.001 versus EGþ P4, two-way analysis of variance followed by a post hoc analysis. (b–c) Western blot analysis in EG-treated rat
kidneys on day 21 following EG treatment for Cu/Zn SOD (b), catalase (c), glutathione peroxidase (c), and b-actin. Data of protein expression
represent means±s.d. *Po0.05 versus untreated control and ##Po0.01 versus EG, one-way analysis of variance followed by a post hoc
analysis. C, untreated control (distilled water); EG, EG-treated group (0.8% EG/1% ammonium chloride (AC; NH4Cl) in drinking water);
and EGþ P4 and EGþ P20, two PGG-treated groups (0.8% EG/1% ACþ 4 or 20mg/kg of PGG in 2% methylcellulose).
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Republic of Korea) using Hitachi 747 automatic analyzer (Hitachi,
Tokyo, Japan) by ion selective electrode method.
The ion activity product of CaOx (AP (CaOx) indexrat) was
calculated based on the urinary values of oxalate, calcium,
magnesium, citrate, and volume, according to the following
formula: [(4067Ca0.93Ox0.96) (Mg0.55 (Citþ 0.015)0.60
V0.99)], derived from AP (CaOx) Tiselius index,36 originally
used for human urine.7
Immunohistochemistry
Kidney specimens were immediately removed from killed rats and
immunohistochemistry was performed. Kidney tissues were fixed in
10% neutral-buffered formalin overnight, embedded in paraffin,
and sectioned (4mm thickness). Kidney sections were immobilized
and deparaffinized by immersion in xylene, dehydrated in a graded
series of ethanol and washed with distilled water. For antigen
retrieval, the kidney sections were boiled in 10mM sodium citrate
buffer (pH 6.0) for 10min and cooled at room temperature. After
washing with tris-buffered saline (TBS), endogenous peroxidase
activity was blocked by incubation in 3% H2O2–methanol for 10min
at room temperature. The sections were stained with anti-hyaluronic
acid binding protein (Seikagaku, Tokyo, Japan), SOD (Assay
Designs, Ann Arbor, MI), and OPN (Santa Cruz Biotechnologies,
Santa Cruz, CA) overnight at 4 1C using avidin–biotin complex and
diaminobenzidine kits (Vector Lab, Burlingame, CA) and also
counterstained with Mayer’s hematoxylin solution (Sigma chemical,
St Louis, MO).
TUNEL staining was performed using a TdT-FragEL DNA
fragmentation kit (Oncogene, Boston, MA) and counterstained with
methyl green. All stained sections were photographed under an
Axiovert S 100 light microscope (Carl Zeiss) at  400 magnification.
MDA assay
MDA content in serum was measured using Bioxytech MDA-586
Assay kit (OXIS International, Portland, OR).
Cell culture
Human primary renal epithelial cells (HRCs) were isolated from the
urine of a healthy, non-stone-forming male using the method of
Dorrenhaus et al.,37 as previously described.38 Cells were maintained
in Dulbecco’s modified Eagle’s medium (Welgene, Deagu, Republic
of Korea) supplemented with fetal bovine serum and 100U/ml
penicillin and 100 mg/ml streptomycin at 37 1C in a humidified
atmosphere containing 5% CO2.
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Figure 4 | Effect of 1,2,3,4,6-penta-O-galloyl-b-D-glucose (PGG)
on osteopontin (OPN) expression in ethylene glycol
(EG)-treated rat kidneys. (a) Immunohistochemical staining for
OPN in rat kidney tissues (n¼ 6/group) obtained on day 21
following EG treatment was performed and the average number
of stained cells per high power field was counted from three
independent experiments. Data represent means±s.d.
(b) Western blot analysis in EG-treated rat kidneys for OPN and
b-actin. ***Po0.001 versus untreated control; ###Po0.001 versus
EG; and !!!Po0.001 versus EGþ P4, one-way analysis of variance
followed by a post hoc analysis. C, untreated control (distilled
water); EG, EG-treated group (0.8% EG/1% ammonium chloride
(AC; NH4Cl) in drinking water); and EGþ P4 and EGþ P20, two
PGG-treated groups (0.8% EG/1% ACþ 4 or 20mg/kg of PGG
in 2% methylcellulose).
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Figure 5 | Effect of PGG on cell death index TUNEL staining in
EG treated rat kidneys. Cell death was assessed by TUNEL assay
in rat kidney tissues (n¼ 6/group) obtained on day 21 following
EG treatment. Graph represents the average number of TUNEL
positive stained cells per high power field. Data represent
means±s.d. ###Po0.001 versus untreated control, and *Po0.05
and ***Po0.001 versus untreated control, ###Po0.001 versus EG,
two-way analysis of variance followed by a post hoc analysis. C,
untreated control (distilled water); EG, EG treated group (0.8% EG/1%
AC (NH4Cl) in drinking water) and, EGþ P4 and EGþ P20; two
PGG-treated groups (0.8% EG/1% ACþ 4 or 20mg/kg of PGG in
2% methylcellulose).
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Measurement of ROS generation
2,7-Dichlorofluorescein diacetate was used to measure the levels of
ROS induced by oxalate in cultured cells. HRCs (2 105 cells) were
exposed to oxalate (1mM) for 1 h, and then to 20 mM 2,7-
dichlorofluorescein diacetate. After 30min incubation at 37 1C,
fluorescence intensities were measured by flow cytometry (BD
FACSCalibur, Becton Dickinson, Franklin Lakes, NJ).
Western blot analysis
Homogenized kidney tissues were lysed in 500ml of lysis buffer
(50mM Tris-HCl, pH 7.4, 150mM NaCl, 1% Triton X-100, 0.1% SDS,
1mM EDTA, 1mM Na3VO4, 1mM NaF, protease inhibitor cocktail) for
20min on ice. Lysates were centrifuged at 14,000 g for 20min at 4 1C
and the protein content of the supernatant was measured using a Bio-
Rad DC protein assay kit II (Bio-Rad, Hercules, CA). The lysates
containing 20mg of protein were mixed with 4 NuPAGE LDS
sample buffer and boiled for 5min. The proteins were separated on
4–12% NuPAGE Bis-Tris gels (Invitrogen, Carlsbad, CA) with 1
NuPAGE MES SDS running buffer and then electrotransferred onto a
Hybond enhanced chemiluminescence transfer membrane with
transfer buffer (25mM Tris, 250mM glycine, 20% methanol) at
300mA for 90min. The membranes were blocked with 5% nonfat dry
milk in TBS buffer containing 0.1% Tween-20 (TBST) for 90min at
room temperature, then immunoblotted with primary antibodies of
rabbit polyclonal to catalase (1:1000) (Ab Frontier, Yongin, Republic
of Korea), SOD (1:1000) (Assay Designs), glutathione peroxidase
(1:1000) (Ab Frontier), mouse polyclonal to osteopontin (OPN)
(1:1000) (Santa Cruz Biotechnologies) in TBST that contained 5%
nonfat dry milk in overnight at 4 1C. After three successive washing
with TBST for 10min, the membranes were incubated with goat
anti-mouse immunoglobulin-G horseradish peroxidase-conjugated
secondary antibody (1:3000 dilution) or goat anti-rabbit immuno-
globulin-G horseradish peroxidase-conjugated secondary antibody
(1:3000 dilution) in TBST that contained 3% nonfat dry milk for
90min at room temperature. After three successive washing with TBST
for 10min, the proteins were developed using an enhanced chemi-
luminescence Western blotting detection kit and exposed to X-ray films.
Protein contents were normalized by probing the same membrane with
anti-b-actin antibody (Sigma). For b-actin detection, previously used
membranes were soaked in stripping buffer (62.5mM Tris-HCl, pH 6.8,
150mM NaCl, 2% SDS, 100mM b-mercaptoethanol) at 65 1C for 30min
and hybridized with anti-b-actin (1:20,000 dilution).
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Figure 6 | Effect of 1,2,3,4,6-penta-O-galloyl-b-D-glucose (PGG) on hyaluronan expression in ethylene glycol (EG)-treated rat
kidneys. (a) Immunohistochemical staining for renal hyaluronan expression in EG-treated rat kidneys (n¼ 6/group) obtained on days 7, 14,
and 21 following EG treatment. (b) The average number of hyaluronan-positive stained cells per high power field. Data represent
means±s.d. *Po0.05 and ***Po0.001 versus untreated control; ###Po0.001 versus EG; and !Po0.05 versus EGþ P4, two-way analysis
of variance followed by a post hoc analysis. C, untreated control (distilled water); EG, EG-treated group (0.8% EG/1% ammonium chloride
(AC; NH4Cl) in drinking water); and EGþ P4 and EGþ P20, two PGG-treated groups (0.8% EG/1% ACþ 4 or 20mg/kg of PGG in 2%
methylcellulose).
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Statistical analyses
All data were expressed as means±s.d. The statistically significant
differences were calculated by Student’s t-test for in vitro assay and
one- or two-way analysis of variance by Duncan’s test for in vivo
assays. P-value o0.05 was considered as statistically significant.
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